STRONG MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
STRONG MEMORIAL HOSPITAL is a 749-bed large academic medical center in MONROE, NY with $3.31B in net patient revenue and a 5.2% operating margin. The hospital serves a payer mix of 14.5% Medicare, 4.8% Medicaid, and 80.7% commercial.
Thesis: Platform Growth. Our ML models identify $244.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.2% to 12.6% (+736bps).
| Net Revenue HCRIS | $3.31B |
| Current EBITDA COMPUTED | $172.1M |
| Operating Margin COMPUTED | 5.2% |
| Occupancy HCRIS | 109.5% |
| Revenue / Bed COMPUTED | $4.4M |
| Net-to-Gross HCRIS | 43.9% |
| Distress Probability ML | 33.5% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of 5.2% places it above the state median. Among 33 size-comparable peers (374-1498 beds), the median margin is -21.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (374-1498), prioritizing same-state peers. 33 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| STRONG MEMORIAL HOSPITAL (Target) | NY | 749 | $3.31B | 5.2% |
| MEMORIAL HOSPITAL FOR CANCER A | NY | 514 | $4.34B | -32.5% |
| MOUNT SINAI HOSPITAL | NY | 1085 | $3.20B | -12.1% |
| MONTEFIORE MEDICAL CENTER | NY | 1410 | $3.01B | -50.0% |
| LONG ISLAND JEWISH MEDICAL CEN | NY | 1161 | $2.97B | -27.0% |
| NORTH SHORE UNIVERSITY HOSPITA | NY | 782 | $2.27B | -50.0% |
| STONY BROOK UNIVERSITY HOSPITA | NY | 725 | $1.90B | -4.9% |
| WESTCHESTER MEDICAL CENTER | NY | 696 | $1.63B | 2.6% |
| KALEIDA HEALTH | NY | 954 | $1.38B | -8.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $244.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $69.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $66.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $65.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $40.3M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $2.1M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $172.1M |
| + RCM Uplift | +$244.0M |
| Pro Forma EBITDA | $416.1M |
| Current Margin | 5.2% |
| Pro Forma Margin | 12.6% |
| WC Released (1x) | $127.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $264.7M | $3.58B | 13.50x | 68.3% |
| Base (11x exit) | 10.0x | 11.0x | $264.7M | $4.02B | 15.18x | 72.3% |
| Bull Case | 9.0x | 11.0x | $238.3M | $4.91B | 20.61x | 83.2% |
| Bull (12x exit) | 9.0x | 12.0x | $238.3M | $5.43B | 22.77x | 86.9% |
| Bear Case | 11.0x | 10.0x | $291.2M | $2.27B | 7.79x | 50.8% |
| Bear (11x exit) | 11.0x | 11.0x | $291.2M | $2.59B | 8.90x | 54.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 33 hospitals with 374-1498 beds
- Same-state prioritization (n=34)
- Comp margins: P25=-32.6% / P50=-21.4% / P75=-11.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.